Cost-effectiveness analysis for SilAtro-5-90 adjuvant treatment in the management of recurrent tonsillitis, compared with usual care only View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2021-09-19

AUTHORS

Thomas Ostermann, A-La Park, Sabine De Jaegere, Katharina Fetz, Petra Klement, Christa Raak, David McDaid

ABSTRACT

PURPOSE: Antibiotics are one possible treatment for patients with recurrent acute throat infections (ATI), but effectiveness can be modest. In view of worries over antibiotic resistance, treatment pathways that reduce recurrence of ATI are essential from a public health perspective. Integrative treatment strategies can be an option but there is still a high demand to provide evidence of their cost effectiveness. METHODS: We constructed a 4-state Markov model to compare the cost-effectiveness of SilAtro-5-90 as adjuvant homeopathic therapy to care as usual with care as usual alone in reducing the recurrence of ATI for children and adults with suspected moderate recurrent tonsillitis. The analysis was performed from a societal perspective in Germany over a 2-year period. Results are reported separately for children < 12 and for individuals aged 12 and over. The model draws on evidence from a multi-centre randomised clinical trial that found this strategy effective in reducing recurrence of ATI. Costs in 2019 € and outcomes after 1 year are discounted at a rate of 3% per annum. RESULTS: For adults and adolescents aged 12 years and over, incremental cost per ATI averted in the adjuvant therapy group was €156.64. If individuals enter the model on average with a history of 3.33 previous ATIs, adjuvant therapy has both lower costs and better outcomes than care as usual. For children (< 12 years) adjuvant therapy had both lower costs and ATI than care as usual. The economic case is stronger if adjuvant treatment reduces surgical referral. At a hypothetical cost per ATI averted threshold of €1000 probabilistic sensitivity analysis suggests Silatro-5-90 has a 65% (adults) and 71% (children) chance of being cost-effective. CONCLUSION: Our results indicate the importance of considering homeopathy as adjuvant therapy in the treatment of ATIs in individuals with recurrent tonsillitis from a socio-economic perspective. Further evaluation should assess how differences in uptake and sustained use of homeopathic adjuvant therapy, as well as changing patterns of antibiotic prescribing, impact on cost effectiveness. More... »

PAGES

60

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12962-021-00313-4

DOI

http://dx.doi.org/10.1186/s12962-021-00313-4

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1141228005

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/34538271


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/14", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Economics", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1402", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Applied Economics", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Psychology and Psychotherapy, Witten/Herdecke University, Alfred-Herrhausen-Stra\u00dfe 50, 58448 Witten, Germany", 
          "id": "http://www.grid.ac/institutes/grid.412581.b", 
          "name": [
            "Department of Psychology and Psychotherapy, Witten/Herdecke University, Alfred-Herrhausen-Stra\u00dfe 50, 58448 Witten, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ostermann", 
        "givenName": "Thomas", 
        "id": "sg:person.01365146325.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365146325.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Care Policy and Evaluation Centre, Department of Health Policy, London School of Economics and Political Science, Houghton Street, London, WC2A 2AE UK", 
          "id": "http://www.grid.ac/institutes/grid.13063.37", 
          "name": [
            "Care Policy and Evaluation Centre, Department of Health Policy, London School of Economics and Political Science, Houghton Street, London, WC2A 2AE UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Park", 
        "givenName": "A-La", 
        "id": "sg:person.01173060413.79", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01173060413.79"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Deutsche Hom\u00f6opathie-Union, DHU-Arzneimittel GmbH & Co. KG, Ottostra\u00dfe 24, 76227 Karlsruhe, Germany", 
          "id": "http://www.grid.ac/institutes/grid.476223.6", 
          "name": [
            "Deutsche Hom\u00f6opathie-Union, DHU-Arzneimittel GmbH & Co. KG, Ottostra\u00dfe 24, 76227 Karlsruhe, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "De Jaegere", 
        "givenName": "Sabine", 
        "id": "sg:person.015501056417.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015501056417.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Psychology and Psychotherapy, Witten/Herdecke University, Alfred-Herrhausen-Stra\u00dfe 50, 58448 Witten, Germany", 
          "id": "http://www.grid.ac/institutes/grid.412581.b", 
          "name": [
            "Department of Psychology and Psychotherapy, Witten/Herdecke University, Alfred-Herrhausen-Stra\u00dfe 50, 58448 Witten, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fetz", 
        "givenName": "Katharina", 
        "id": "sg:person.0747272617.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0747272617.88"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Deutsche Hom\u00f6opathie-Union, DHU-Arzneimittel GmbH & Co. KG, Ottostra\u00dfe 24, 76227 Karlsruhe, Germany", 
          "id": "http://www.grid.ac/institutes/grid.476223.6", 
          "name": [
            "Deutsche Hom\u00f6opathie-Union, DHU-Arzneimittel GmbH & Co. KG, Ottostra\u00dfe 24, 76227 Karlsruhe, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Klement", 
        "givenName": "Petra", 
        "id": "sg:person.01132735603.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132735603.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Integrative Medicine, Witten/Herdecke University, Gerhard-Kienle-Weg 4, 58313 Herdecke, Germany", 
          "id": "http://www.grid.ac/institutes/grid.412581.b", 
          "name": [
            "Institute of Integrative Medicine, Witten/Herdecke University, Gerhard-Kienle-Weg 4, 58313 Herdecke, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Raak", 
        "givenName": "Christa", 
        "id": "sg:person.01222206364.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01222206364.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Care Policy and Evaluation Centre, Department of Health Policy, London School of Economics and Political Science, Houghton Street, London, WC2A 2AE UK", 
          "id": "http://www.grid.ac/institutes/grid.13063.37", 
          "name": [
            "Care Policy and Evaluation Centre, Department of Health Policy, London School of Economics and Political Science, Houghton Street, London, WC2A 2AE UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "McDaid", 
        "givenName": "David", 
        "id": "sg:person.01101756453.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01101756453.36"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s15006-019-1011-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1121958021", 
          "https://doi.org/10.1007/s15006-019-1011-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13063-015-0768-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026923770", 
          "https://doi.org/10.1186/s13063-015-0768-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00405-012-1990-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000417925", 
          "https://doi.org/10.1007/s00405-012-1990-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12913-020-05706-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1130862482", 
          "https://doi.org/10.1186/s12913-020-05706-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12630-017-0888-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085042030", 
          "https://doi.org/10.1007/s12630-017-0888-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12906-015-0569-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012339717", 
          "https://doi.org/10.1186/s12906-015-0569-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00405-014-3312-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016512431", 
          "https://doi.org/10.1007/s00405-014-3312-z"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2021-09-19", 
    "datePublishedReg": "2021-09-19", 
    "description": "PURPOSE: Antibiotics are one possible treatment for patients with recurrent acute throat infections (ATI), but effectiveness can be modest. In view of worries over antibiotic resistance, treatment pathways that reduce recurrence of ATI are essential from a public health perspective. Integrative treatment strategies can be an option but there is still a high demand to provide evidence of their cost effectiveness.\nMETHODS: We constructed a 4-state Markov model to compare the cost-effectiveness of SilAtro-5-90 as adjuvant homeopathic therapy to care as usual with care as usual alone in reducing the recurrence of ATI for children and adults with suspected moderate recurrent tonsillitis. The analysis was performed from a societal perspective in Germany over a 2-year period. Results are reported separately for children < 12 and for individuals aged 12 and over. The model draws on evidence from a multi-centre randomised clinical trial that found this strategy effective in reducing recurrence of ATI. Costs in 2019 \u20ac and outcomes after 1\u00a0year are discounted at a rate of 3% per annum.\nRESULTS: For adults and adolescents aged 12 years and over, incremental cost per ATI averted in the adjuvant therapy group was \u20ac156.64. If individuals enter the model on average with a history of 3.33 previous ATIs, adjuvant therapy has both lower costs and better outcomes than care as usual. For children (< 12 years) adjuvant therapy had both lower costs and ATI than care as usual. The economic case is stronger if adjuvant treatment reduces surgical referral. At a hypothetical cost per ATI averted threshold of \u20ac1000 probabilistic sensitivity analysis suggests Silatro-5-90 has a 65% (adults) and 71% (children) chance of being cost-effective.\nCONCLUSION: Our results indicate the importance of considering homeopathy as adjuvant therapy in the treatment of ATIs in individuals with recurrent tonsillitis from a socio-economic perspective. Further evaluation should assess how differences in uptake and sustained use of homeopathic adjuvant therapy, as well as changing patterns of antibiotic prescribing, impact on cost effectiveness.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s12962-021-00313-4", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1032048", 
        "issn": [
          "1478-7547"
        ], 
        "name": "Cost Effectiveness and Resource Allocation", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "19"
      }
    ], 
    "keywords": [
      "acute throat infections", 
      "adjuvant therapy", 
      "recurrent tonsillitis", 
      "adjuvant treatment", 
      "adjuvant therapy group", 
      "integrative treatment strategies", 
      "probabilistic sensitivity analyses", 
      "public health perspective", 
      "cost-effectiveness analysis", 
      "surgical referral", 
      "usual care", 
      "antibiotic prescribing", 
      "throat infections", 
      "clinical trials", 
      "treatment pathways", 
      "treatment strategies", 
      "therapy group", 
      "homeopathic therapy", 
      "better outcomes", 
      "cost effectiveness", 
      "possible treatment", 
      "therapy", 
      "tonsillitis", 
      "further evaluation", 
      "societal perspective", 
      "recurrence", 
      "incremental cost", 
      "health perspective", 
      "antibiotic resistance", 
      "treatment", 
      "care", 
      "adults", 
      "outcomes", 
      "children", 
      "sustained use", 
      "hypothetical costs", 
      "individuals", 
      "prescribing", 
      "patients", 
      "referral", 
      "years", 
      "infection", 
      "averted", 
      "trials", 
      "evidence", 
      "antibiotics", 
      "homeopathy", 
      "adolescents", 
      "group", 
      "options", 
      "pathway", 
      "uptake", 
      "effectiveness", 
      "worry", 
      "period", 
      "management", 
      "differences", 
      "strategies", 
      "history", 
      "evaluation", 
      "analysis", 
      "cases", 
      "sensitivity analysis", 
      "chance", 
      "rate", 
      "resistance", 
      "results", 
      "average", 
      "use", 
      "threshold", 
      "economic case", 
      "patterns", 
      "annum", 
      "model", 
      "impact", 
      "importance", 
      "cost", 
      "perspective", 
      "Markov model", 
      "low cost", 
      "high demand", 
      "Germany", 
      "view", 
      "socio-economic perspective", 
      "demand", 
      "recurrent acute throat infections", 
      "view of worries", 
      "recurrence of ATI", 
      "SilAtro-5", 
      "adjuvant homeopathic therapy", 
      "moderate recurrent tonsillitis", 
      "ATI averted", 
      "previous ATIs", 
      "children (< 12 years) adjuvant therapy", 
      "treatment of ATIs", 
      "homeopathic adjuvant therapy"
    ], 
    "name": "Cost-effectiveness analysis for SilAtro-5-90 adjuvant treatment in the management of recurrent tonsillitis, compared with usual care only", 
    "pagination": "60", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1141228005"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12962-021-00313-4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "34538271"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12962-021-00313-4", 
      "https://app.dimensions.ai/details/publication/pub.1141228005"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:57", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_883.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s12962-021-00313-4"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12962-021-00313-4'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12962-021-00313-4'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12962-021-00313-4'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12962-021-00313-4'


 

This table displays all metadata directly associated to this object as RDF triples.

235 TRIPLES      22 PREDICATES      129 URIs      114 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12962-021-00313-4 schema:about anzsrc-for:14
2 anzsrc-for:1402
3 schema:author N5bfd8ae2e3c84dcda1c20c3cc06278b0
4 schema:citation sg:pub.10.1007/s00405-012-1990-y
5 sg:pub.10.1007/s00405-014-3312-z
6 sg:pub.10.1007/s12630-017-0888-y
7 sg:pub.10.1007/s15006-019-1011-9
8 sg:pub.10.1186/s12906-015-0569-8
9 sg:pub.10.1186/s12913-020-05706-4
10 sg:pub.10.1186/s13063-015-0768-0
11 schema:datePublished 2021-09-19
12 schema:datePublishedReg 2021-09-19
13 schema:description PURPOSE: Antibiotics are one possible treatment for patients with recurrent acute throat infections (ATI), but effectiveness can be modest. In view of worries over antibiotic resistance, treatment pathways that reduce recurrence of ATI are essential from a public health perspective. Integrative treatment strategies can be an option but there is still a high demand to provide evidence of their cost effectiveness. METHODS: We constructed a 4-state Markov model to compare the cost-effectiveness of SilAtro-5-90 as adjuvant homeopathic therapy to care as usual with care as usual alone in reducing the recurrence of ATI for children and adults with suspected moderate recurrent tonsillitis. The analysis was performed from a societal perspective in Germany over a 2-year period. Results are reported separately for children < 12 and for individuals aged 12 and over. The model draws on evidence from a multi-centre randomised clinical trial that found this strategy effective in reducing recurrence of ATI. Costs in 2019 € and outcomes after 1 year are discounted at a rate of 3% per annum. RESULTS: For adults and adolescents aged 12 years and over, incremental cost per ATI averted in the adjuvant therapy group was €156.64. If individuals enter the model on average with a history of 3.33 previous ATIs, adjuvant therapy has both lower costs and better outcomes than care as usual. For children (< 12 years) adjuvant therapy had both lower costs and ATI than care as usual. The economic case is stronger if adjuvant treatment reduces surgical referral. At a hypothetical cost per ATI averted threshold of €1000 probabilistic sensitivity analysis suggests Silatro-5-90 has a 65% (adults) and 71% (children) chance of being cost-effective. CONCLUSION: Our results indicate the importance of considering homeopathy as adjuvant therapy in the treatment of ATIs in individuals with recurrent tonsillitis from a socio-economic perspective. Further evaluation should assess how differences in uptake and sustained use of homeopathic adjuvant therapy, as well as changing patterns of antibiotic prescribing, impact on cost effectiveness.
14 schema:genre article
15 schema:inLanguage en
16 schema:isAccessibleForFree true
17 schema:isPartOf Nb2b3ac01a29a493e8be8e46bb9ef5d04
18 Nc93a18ae1bc5489a85cf9aaa17717297
19 sg:journal.1032048
20 schema:keywords ATI averted
21 Germany
22 Markov model
23 SilAtro-5
24 acute throat infections
25 adjuvant homeopathic therapy
26 adjuvant therapy
27 adjuvant therapy group
28 adjuvant treatment
29 adolescents
30 adults
31 analysis
32 annum
33 antibiotic prescribing
34 antibiotic resistance
35 antibiotics
36 average
37 averted
38 better outcomes
39 care
40 cases
41 chance
42 children
43 children (< 12 years) adjuvant therapy
44 clinical trials
45 cost
46 cost effectiveness
47 cost-effectiveness analysis
48 demand
49 differences
50 economic case
51 effectiveness
52 evaluation
53 evidence
54 further evaluation
55 group
56 health perspective
57 high demand
58 history
59 homeopathic adjuvant therapy
60 homeopathic therapy
61 homeopathy
62 hypothetical costs
63 impact
64 importance
65 incremental cost
66 individuals
67 infection
68 integrative treatment strategies
69 low cost
70 management
71 model
72 moderate recurrent tonsillitis
73 options
74 outcomes
75 pathway
76 patients
77 patterns
78 period
79 perspective
80 possible treatment
81 prescribing
82 previous ATIs
83 probabilistic sensitivity analyses
84 public health perspective
85 rate
86 recurrence
87 recurrence of ATI
88 recurrent acute throat infections
89 recurrent tonsillitis
90 referral
91 resistance
92 results
93 sensitivity analysis
94 societal perspective
95 socio-economic perspective
96 strategies
97 surgical referral
98 sustained use
99 therapy
100 therapy group
101 threshold
102 throat infections
103 tonsillitis
104 treatment
105 treatment of ATIs
106 treatment pathways
107 treatment strategies
108 trials
109 uptake
110 use
111 usual care
112 view
113 view of worries
114 worry
115 years
116 schema:name Cost-effectiveness analysis for SilAtro-5-90 adjuvant treatment in the management of recurrent tonsillitis, compared with usual care only
117 schema:pagination 60
118 schema:productId N4221b0931f6f4219aec1119ae1fec720
119 Na222d9006a4b458caf67ddc8413f72ef
120 Nec55fa85c54d43c48f58ab4a382e9e57
121 schema:sameAs https://app.dimensions.ai/details/publication/pub.1141228005
122 https://doi.org/10.1186/s12962-021-00313-4
123 schema:sdDatePublished 2022-01-01T18:57
124 schema:sdLicense https://scigraph.springernature.com/explorer/license/
125 schema:sdPublisher N7a682f4dbe0f460aad20acc817cc2d7a
126 schema:url https://doi.org/10.1186/s12962-021-00313-4
127 sgo:license sg:explorer/license/
128 sgo:sdDataset articles
129 rdf:type schema:ScholarlyArticle
130 N006b3b261e95464a83bc86f6cd8d3844 rdf:first sg:person.01132735603.17
131 rdf:rest N66f0540a466d41d080d66380343faaf0
132 N4221b0931f6f4219aec1119ae1fec720 schema:name pubmed_id
133 schema:value 34538271
134 rdf:type schema:PropertyValue
135 N4540ee7cd8d54014856ca596b1a9991f rdf:first sg:person.01173060413.79
136 rdf:rest Ne63b8581fb9844bdb172a86947fe2e4a
137 N5bfd8ae2e3c84dcda1c20c3cc06278b0 rdf:first sg:person.01365146325.77
138 rdf:rest N4540ee7cd8d54014856ca596b1a9991f
139 N66f0540a466d41d080d66380343faaf0 rdf:first sg:person.01222206364.14
140 rdf:rest N88ba3273e8794f26aeaec5c7b7a1b19e
141 N7a682f4dbe0f460aad20acc817cc2d7a schema:name Springer Nature - SN SciGraph project
142 rdf:type schema:Organization
143 N88ba3273e8794f26aeaec5c7b7a1b19e rdf:first sg:person.01101756453.36
144 rdf:rest rdf:nil
145 Na222d9006a4b458caf67ddc8413f72ef schema:name doi
146 schema:value 10.1186/s12962-021-00313-4
147 rdf:type schema:PropertyValue
148 Nb2b3ac01a29a493e8be8e46bb9ef5d04 schema:issueNumber 1
149 rdf:type schema:PublicationIssue
150 Nc93a18ae1bc5489a85cf9aaa17717297 schema:volumeNumber 19
151 rdf:type schema:PublicationVolume
152 Nd073fc186b30467c8682fc8dce43e1a9 rdf:first sg:person.0747272617.88
153 rdf:rest N006b3b261e95464a83bc86f6cd8d3844
154 Ne63b8581fb9844bdb172a86947fe2e4a rdf:first sg:person.015501056417.80
155 rdf:rest Nd073fc186b30467c8682fc8dce43e1a9
156 Nec55fa85c54d43c48f58ab4a382e9e57 schema:name dimensions_id
157 schema:value pub.1141228005
158 rdf:type schema:PropertyValue
159 anzsrc-for:14 schema:inDefinedTermSet anzsrc-for:
160 schema:name Economics
161 rdf:type schema:DefinedTerm
162 anzsrc-for:1402 schema:inDefinedTermSet anzsrc-for:
163 schema:name Applied Economics
164 rdf:type schema:DefinedTerm
165 sg:journal.1032048 schema:issn 1478-7547
166 schema:name Cost Effectiveness and Resource Allocation
167 schema:publisher Springer Nature
168 rdf:type schema:Periodical
169 sg:person.01101756453.36 schema:affiliation grid-institutes:grid.13063.37
170 schema:familyName McDaid
171 schema:givenName David
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01101756453.36
173 rdf:type schema:Person
174 sg:person.01132735603.17 schema:affiliation grid-institutes:grid.476223.6
175 schema:familyName Klement
176 schema:givenName Petra
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132735603.17
178 rdf:type schema:Person
179 sg:person.01173060413.79 schema:affiliation grid-institutes:grid.13063.37
180 schema:familyName Park
181 schema:givenName A-La
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01173060413.79
183 rdf:type schema:Person
184 sg:person.01222206364.14 schema:affiliation grid-institutes:grid.412581.b
185 schema:familyName Raak
186 schema:givenName Christa
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01222206364.14
188 rdf:type schema:Person
189 sg:person.01365146325.77 schema:affiliation grid-institutes:grid.412581.b
190 schema:familyName Ostermann
191 schema:givenName Thomas
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365146325.77
193 rdf:type schema:Person
194 sg:person.015501056417.80 schema:affiliation grid-institutes:grid.476223.6
195 schema:familyName De Jaegere
196 schema:givenName Sabine
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015501056417.80
198 rdf:type schema:Person
199 sg:person.0747272617.88 schema:affiliation grid-institutes:grid.412581.b
200 schema:familyName Fetz
201 schema:givenName Katharina
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0747272617.88
203 rdf:type schema:Person
204 sg:pub.10.1007/s00405-012-1990-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1000417925
205 https://doi.org/10.1007/s00405-012-1990-y
206 rdf:type schema:CreativeWork
207 sg:pub.10.1007/s00405-014-3312-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1016512431
208 https://doi.org/10.1007/s00405-014-3312-z
209 rdf:type schema:CreativeWork
210 sg:pub.10.1007/s12630-017-0888-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1085042030
211 https://doi.org/10.1007/s12630-017-0888-y
212 rdf:type schema:CreativeWork
213 sg:pub.10.1007/s15006-019-1011-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1121958021
214 https://doi.org/10.1007/s15006-019-1011-9
215 rdf:type schema:CreativeWork
216 sg:pub.10.1186/s12906-015-0569-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012339717
217 https://doi.org/10.1186/s12906-015-0569-8
218 rdf:type schema:CreativeWork
219 sg:pub.10.1186/s12913-020-05706-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1130862482
220 https://doi.org/10.1186/s12913-020-05706-4
221 rdf:type schema:CreativeWork
222 sg:pub.10.1186/s13063-015-0768-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026923770
223 https://doi.org/10.1186/s13063-015-0768-0
224 rdf:type schema:CreativeWork
225 grid-institutes:grid.13063.37 schema:alternateName Care Policy and Evaluation Centre, Department of Health Policy, London School of Economics and Political Science, Houghton Street, London, WC2A 2AE UK
226 schema:name Care Policy and Evaluation Centre, Department of Health Policy, London School of Economics and Political Science, Houghton Street, London, WC2A 2AE UK
227 rdf:type schema:Organization
228 grid-institutes:grid.412581.b schema:alternateName Department of Psychology and Psychotherapy, Witten/Herdecke University, Alfred-Herrhausen-Straße 50, 58448 Witten, Germany
229 Institute of Integrative Medicine, Witten/Herdecke University, Gerhard-Kienle-Weg 4, 58313 Herdecke, Germany
230 schema:name Department of Psychology and Psychotherapy, Witten/Herdecke University, Alfred-Herrhausen-Straße 50, 58448 Witten, Germany
231 Institute of Integrative Medicine, Witten/Herdecke University, Gerhard-Kienle-Weg 4, 58313 Herdecke, Germany
232 rdf:type schema:Organization
233 grid-institutes:grid.476223.6 schema:alternateName Deutsche Homöopathie-Union, DHU-Arzneimittel GmbH & Co. KG, Ottostraße 24, 76227 Karlsruhe, Germany
234 schema:name Deutsche Homöopathie-Union, DHU-Arzneimittel GmbH & Co. KG, Ottostraße 24, 76227 Karlsruhe, Germany
235 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...